Mycotopia Therapies, Inc. (TPIA)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -106.76 Thousand | -656.62 Thousand | -235.48 Thousand | -302.8 Thousand | 98.66 Thousand | -68.53 Thousand |
| Net Income | -1.18 Million | -2.75 Million | -2.82 Million | -242.2 Thousand | 4803.00 | 61.2 Thousand |
| Depreciation & Amortization | 61.21 Thousand | 1001.00 | 249.00 | 548.00 | 323.00 | 672.00 |
| Deferred income taxes | - | - | -4.31 Million | -145.51 Thousand | - | - |
| Stock-based compensation | 635.00 | 1.02 Million | 4.31 Million | 44.6 Thousand | - | - |
| Change in working capital | 577.23 Thousand | 455.36 Thousand | 179.37 Thousand | -45.2 Thousand | 54.27 Thousand | -39.72 Thousand |
| Other non-cash items | 558.56 Thousand | 764.02 Thousand | 2.4 Million | 84.97 Thousand | 39.26 Thousand | -90.68 Thousand |
| Investing Cash Flow | - | - | -2746.00 | -349 Thousand | -1000.00 | - |
| Investments in PPE | - | - | -2746.00 | - | - | - |
| Acquisitions | - | - | - | -350 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 1000.00 | -1000.00 | - |
| Financing Cash Flow | - | -225 Thousand | 1.39 Million | 125 Thousand | - | - |
| Debt repayment | - | -625 Thousand | -1.39 Million | -125 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 150 Thousand | - | - | - | - |
| Other Financing Activities | - | 250 Thousand | 2.79 Million | 250 Thousand | - | - |
| Accounts receivables | - | - | - | 9610.00 | - | -27.73 Thousand |
| Accounts payables | 160.1 Thousand | 465.7 Thousand | 170.81 Thousand | -54.81 Thousand | 52.72 Thousand | 3238.00 |
| Inventory | - | - | - | -9610.00 | - | -4381.00 |
| Other working capital | 577.23 Thousand | -10.33 Thousand | 8563.00 | 9610.00 | 1547.00 | -42.96 Thousand |
| Cash at beginning of period | 385.89 Thousand | 1.26 Million | 110.74 Thousand | 709.16 Thousand | 611.49 Thousand | 680.03 Thousand |
| Cash at end of period | 279.13 Thousand | 385.89 Thousand | 1.26 Million | 57.35 Thousand | 709.16 Thousand | 611.49 Thousand |
| Capital Expenditure | - | - | -2746.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | -125 Thousand | - | - |
| Net cash flow / Change in cash | -106.76 Thousand | -881.62 Thousand | 1.15 Million | -651.8 Thousand | 97.66 Thousand | -68.53 Thousand |
| Free Cash Flow | -106.76 Thousand | -656.62 Thousand | -238.22 Thousand | -302.8 Thousand | 98.66 Thousand | -68.53 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -470.67 Thousand | -425.94 Thousand | -1.18 Million | -290.96 Thousand | -308.7 Thousand | -278.68 Thousand |
| Depreciation & Amortization | 166.3 Thousand | 166.3 Thousand | 61.21 Thousand | 60.47 Thousand | 252.00 | 249.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 635.00 | -43.75 Thousand | - | 44.38 Thousand |
| Change in working capital | 213.84 Thousand | 176.57 Thousand | 577.23 Thousand | 187.29 Thousand | 172.87 Thousand | 78.79 Thousand |
| Other non-cash items | 332.61 Thousand | 341.96 Thousand | 558.56 Thousand | 126.28 Thousand | 113.66 Thousand | 137.12 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 165 Thousand | - | - | - | - |
| Debt repayment | - | -165 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 165 Thousand | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 62.58 Thousand | 49.35 Thousand | 160.1 Thousand | -13.82 Thousand | 100.87 Thousand | -65.2 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 213.84 Thousand | 176.57 Thousand | 577.23 Thousand | 187.29 Thousand | 72 Thousand | 144 Thousand |
| Cash at beginning of period | 370.42 Thousand | 279.13 Thousand | 385.89 Thousand | 316.98 Thousand | 338.89 Thousand | 357.02 Thousand |
| Cash at end of period | 279.9 Thousand | 370.42 Thousand | 279.13 Thousand | 279.13 Thousand | 316.98 Thousand | 338.89 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -90.52 Thousand | 91.29 Thousand | -106.76 Thousand | -37.85 Thousand | -21.9 Thousand | -18.13 Thousand |
| Free Cash Flow | -90.52 Thousand | -73.7 Thousand | -106.76 Thousand | -37.85 Thousand | -21.9 Thousand | -18.13 Thousand |
RAMAPETRO
QING
SWOEF
8917
MTMH
VLI